OIG - Office of Inspector General
08/26/2026 | Press release | Distributed by Public on 08/27/2026 08:05
DermTech Inc. to Pay Up to $5M to Resolve Allegations It Submitted False Claims to Medicare for Unreliable Skin Cancer Tests
DermTech Inc. to Pay Up to $5M to Resolve Allegations It Submitted False Claims to Medicare for Unreliable Skin Cancer Tests
A skin cancer testing company formerly known as DermTech Inc. has agreed to settle allegations that it violated the False Claims Act by knowingly submitting false claims for unreliable skin cancer tests to the Medicare program. DermTech is now liquidating as DTech Liquidating Inc. after filing for Chapter 11 bankruptcy in the District of Delaware in June 2024. As part of the resolution announced today, the United States received an Allowed Class Three General Unsecured Claim of $5,038,011 in the bankruptcy proceeding.
Read more on https://www.justice.gov
Action Details
- Date:Aug. 26, 2026, 9:46 a.m.
- Agency:U.S. Department of Justice
-
Enforcement Types:
- Criminal and Civil Actions
OIG - Office of Inspector General published this content on August 26, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on August 27, 2026 at 14:05 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]